2024
Filter by topic
14-Nov-24
Convatec responds to Local Coverage Determinations (LCDs) on skin substitutes
Corporate12-Nov-24
Trading update for the ten months ended 31 October 2024
Corporate Financial Performance21-Oct-24
Convatec collaborates with AbbVie for VYALEV™ therapy for the treatment of advanced Parkinson’s disease in the United States
Corporate Infusion Care10-Oct-24
Convatec update on InnovaMatrix® AC clinical data – second randomised controlled trial authorised
Corporate Advanced Wound Care20-Sep-24
Convatec update on InnovaMatrix® AC clinical data
Corporate Advanced Wound Care21-Aug-24
Comment on the announcement of CMS changes to catheter codes
Corporate Continence Care01-Aug-24
Convatec me+ Companion™ App offers support for millions of intermittent catheter users
Continence Care30-Jul-24
Interim Results for the six months ended 30 June 2024
Corporate Financial Performance26-Jul-24
Convatec’s pioneering catheter for women continues to scale up in Europe
Continence Care16-May-24
AGM trading update for the four months ended 30 April 2024
Corporate Financial Performance01-May-24
Convatec unveils significant advanced wound care clinical study results
Advanced Wound Care26-Apr-24
Comment on proposed draft Local Coverage Determinations (LCDs) on skin substitutes
Corporate06-Mar-24
Annual Results for the twelve months ended 31 December 2023
Corporate Financial Performance29-Feb-24
Convatec launches new Esteem Body™ with Leak Defense™
Ostomy Care11-Jan-24
Convatec expands support for people living with advanced Parkinson´s disease
Infusion Care